Spectrum Vascular Acquires Piccolo Medical, Expediting Roll Out of Next-Generation Catheter Navigation Technology
Published: 24 Jun 2026
Author: Towards Healthcare
A key provider of vascular access and medication management products, Spectrum Vascular (‘Spectrum’), announced that it acquired Piccolo Medical (‘Piccolo’), a pioneer of state-of-the-art catheter guidance products. This alliance emphasizes unveiling next-generation catheter guidance technology to the market & highlights a milestone step forward in Spectrum's mission to deliver a comprehensive, distinguished vascular access solution to the clinical community.
Augustus Shanahan, CEO of Piccolo,said that respective partnering explores an electrifying new chapter for their firm & for vascular access. On the other side, Kenneth Miller, CEO of Spectrum, replied that this acquisition of Piccolo Medical shows a pivotal effort in their mission to revolutionize vascular access.This will integrate Piccolo's advanced navigation technology with Spectrum's vascular access portfolio & commercial reach.
According to Towards Healthcare, the U.S. antimicrobial catheters market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 1.27 billion in 2026 to approximately USD 2.52 billion by 2035, representing a compound annual growth rate (CAGR) of 7.9% from 2026 to 2035.Rising cases of Catheter-Associated Urinary Tract Infections (CAUTIs) & Catheter-Related Bloodstream Infections (CRBSIs), with stricter regulatory policies, drive the adoption of specialized catheters to enhance patient outcomes & reduce hospital expenditures.
About Spectrum Vascular
Spectrum Vascular, supported by SK Capital Partners, is a major provider of vascular access & medication management products, focused on lowering healthcare-acquired infections. This firm has a mission of increasing the lives of patients across the globe by facilitating caregivers with high-quality, novel products with remarkable customer service.
About Piccolo Medical
Piccolo Medical is a San Francisco-based medical device company & developer in catheter navigation & tip confirmation technology. This leader, founded in 2016, was dragged out of the Theranova medical device incubator & has been funded through private investors, coupled with prestigious grant awards from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
The market will promote the latest nanotechnology & novel technologies.
According to Towards Healthcare, in the future, the U.S. antimicrobial catheters market will have significant opportunities in next-generation nanotechnology. This includes smart materials capable of releasing antimicrobial agents in response to infection biomarkers. Besides this, several leaders are aiming to employ organic & polymer-based technologies to overcome issues regarding bacterial resistance & foster non-antibiotic infection-prevention.